ADP 12778
Alternative Names: ADP-12778Latest Information Update: 28 Jun 2022
At a glance
- Originator Almirall S.A.
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Atopic dermatitis
Most Recent Events
- 28 Jun 2022 No recent reports of development identified for research development in Atopic-dermatitis in Spain
- 22 May 2018 Early research in Atopic dermatitis in Spain (unspecified route) (Almirall pipeline, May 2018)